A Primer on Interstitial Lung Disease and Thoracic Radiation
Christopher D. Goodman(London Health Sciences Centre), David A. Palma(Western University), George Rodrigues(London Health Sciences Centre), Christopher J. Ryerson(University of British Columbia), Inderdeep Dhaliwal(Western University), Suresh Senan(Amsterdam Neuroscience), Joanna Laba(London Health Sciences Centre), Suzan F. M. Nijman(Amsterdam University Medical Centers), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Esther J. Nossent(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 86
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k